Author:
Niederle N.,Weidmann B.,Stuschke M.,Schirren J.
Publisher
Springer Berlin Heidelberg
Reference126 articles.
1. Aisner J, Whitacre M, van Echo DA, Fuks JZ (1984) Cyclophosphamide, doxorubicin and etoposide (CAE) for the treatment of small cell lung cancer. In: Issel BF, Muggia FM, Carter SK (eds) Etoposide (VP-16). Current status and new developments. Academic Press, New York, pp171–182
2. Alba E, Breton JJ, Alonso L et al (1992) Alternating chemotherapy for small-cell lung cancer. A twelve-week schedule of six drugs. Ann Oncol 3:31–35
3. Alberg AJ, Samet JM (2003) Epidemiology of lung cancer. Chest 123:21S–49S
4. Allan SG, Gregor A, Cornbleet MA et al (1984) Phase II trial of vindesine and VP 16 in the palliation of poor-prognosis patients and elderly patients with small cell lung cancer. Cancer Chemother Pharmacol 13:106–108
5. Ardizzoni A, Tjan-Heinen VCG, Postmus PE et al (2002) Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer — Lung Cancer Group phase III trial — 08923. J Clin Oncol 20:3947–3955